Dyne Therapeutics, Inc. Common Stock (NASDAQ: DYN) last traded at $16.30, down 2.07% on the session. The quote above updates while this page is open; the figures below are drawn from Dyne Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Dyne Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker DYN. Its market capitalisation is $3.04 billion.
Valuation measures for Dyne Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.04B |
|---|---|
| Enterprise value | $2.66B |
| Price / book | 4.33 |
| Beta | 2.08 |
Trailing-twelve-month figures tagged in Dyne Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$519.41M |
| EPS (TTM) | -$3.26 |
|---|
| Return on equity | -73.97% |
|---|
| Cash | $676.11M |
|---|
Range and volume for DYN over the past 52 weeks.
| 52-week high | $27.31 |
|---|---|
| 52-week low | $13.73 |
| Volume | 467.3K |
| Average volume | 2.84M |
| Previous close | $16.64 |
Invest a chosen dollar amount in Dyne Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DYN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.